A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
Anja Tränkner, Christian Sander, Peter SchönknechtDepartment of Psychiatry and Psychotherapy, University Hospital Leipzig, Leipzig, GermanyAbstract: The anticonvulsant drug lamotrigine (LTG), a sodium channel blocker and inhibitor of glutamate release, has been found to hav...
Guardado en:
Autores principales: | Tränkner A, Sander C, Schönknecht P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8010f925b61442a682ccbcea6297c6bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-term efficacy and safety of lamotrigine for all types of bipolar disorder
por: Watanabe Y, et al.
Publicado: (2017) -
New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Nurcan Üçeyler, et al.
Publicado: (2008) -
Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis
por: Andreas Rogalewski, et al.
Publicado: (2007) -
Do neurologists in Germany adhere to the national Parkinson's disease guideline?
por: Sabrina Schröder, et al.
Publicado: (2011) -
Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
por: Terao T, et al.
Publicado: (2017)